Clinical Trials

Clinical Trial Detail

Return to search results.

Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) with Autologous Stem Cell Support for Resistant/Recurrent High-Risk Neuroblastoma (IND #69,112)

Research Study Number       NANT 99-02
    
Principal Investigator       Julie Park, MD
    
Phase       I

Look up trial at NIH



Research Study Number       NANT 99-02
    
Contact       Seattle Children’s Outpatient Attending MD
    
Telephone       (206) 987-2106
    
Other URLs that may be
of interest include
      http://nant.org/
http://cancer.seattlechildrens.org/
   

Keywords
Bone Marrow and Hematopoietic Stem Cell Transplant (BMT and HSCT); Neuroblastoma; Solid Tumors

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.